Completed NA INTERVENTIONAL 1-arm NCT02885662

Study of CS-3150 in Patients With Primary Aldosteronism

A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism

Sponsor: Daiichi Sankyo Co., Ltd.

Interventions CS-3150

Updated 10 times since 2017 Last updated: Dec 19, 2018 Started: Sep 30, 2016 Primary completion: Jul 20, 2017 Completion: Jul 20, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Primary Aldosteronism, this trial is completed. The trial is conducted by Daiichi Sankyo Co., Ltd. and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Mar 2024 [monthly]

Completed NA
Jan 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 5 earlier versions

Jun 2018 — Jan 2019 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2017 — Sep 2017 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting · Phase: PHASE3 → NA
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo Co., Ltd.

Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yokohama, Japan